Neurobehavioural basis for the pharmacotherapy of alcoholism: Current and future directions

Alcohol and Alcoholism

Volumn 31, Issue SUPPL. 1, 1996, Pages 43-53

  Anton, Raymond F ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; BUSPIRONE; CITALOPRAM; DESIPRAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENDORPHIN; FLUOXETINE; IMIPRAMINE; LITHIUM; NALMEFENE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE ANTAGONIST; RITANSERIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROIC ACID; ZIMELDINE; NARCOTIC ANTAGONIST; SEROTONIN;

AFFECTIVE NEUROSIS; ALCOHOL CONSUMPTION; ALCOHOLISM; ANALGESIA; ANXIETY; BRAIN LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; DATA ANALYSIS; DRUG EFFICACY; HUMAN; MORBIDITY; NONHUMAN; OBSESSION; PAIN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REWARD; SENSITIZATION; STRESS; FEMALE; MALE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; REVIEW;

ALCOHOLISM; BROMOCRIPTINE; DOPAMINE AGONISTS; FEMALE; FLUOXETINE; HUMANS; MALE; MODELS, PSYCHOLOGICAL; NALTREXONE; NARCOTIC ANTAGONISTS; REWARD; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0029925524     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.alcalc.a008217     Document Type: Conference Paper

References (69)

1. Anthenelli, R. M. and Schuckit, M. A. (1993) Affective and anxiety disorders and alcohol and drug dependence: diagnosis and treatment. Journal of Addictive Diseases 12, 73-87.
2. Anton, R. F. (1995) New directions in the pharmacotherapy of alcoholism. Psychiatric Annals 25, 353-362.
3. Anton, R. F., Moak, D. H. and Latham, P. (1995) The obsessive compulsive drinking scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcoholism: Clinical and Experimental Research 19, 92-99.
4. Balldin, J., Berggren, U., Engel, J., Eriksson, M., Hård, E. and Söderpalm, B. (1994) Effect of citalopram on alcohol intake in heavy drinkers. Alcoholism: Clinical and Experimental Research 18, 1133-1136.
5. Borg, V. (1983) Bromocriptine in the prevention of alcohol abuse. Acta Psychiatrica Scandinavica 68, 100-110.
6. Brady, K. T. and Roberts, J. M. (1995) The pharmacotherapy of dual diagnosis. Psychiatric Annals 25, 344-352.
7. Brady, K. T., Sonne, S. C., Anton, R. and Ballenger, J. C. (1995) Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. Journal of Clinical Psychiatry 56, 118-121.
8. Brady, K. T., Sonne, S. C. and Roberts, J. M. (1995) Sertraline treatment of comorbid post traumatic stress disorder in alcohol dependence. Journal of Clinical Psychiatry 56, 502-505.
9. Burnam, M. A., Stein, J. A., Golding, J. M., Siegel, J. M., Sorenson, S. B., Forsythie, A. B. and Telles, C. A. (1988) Sexual assault and mental disorders in a community population. Journal of Consulting and Clinical Psychology 56, 843-850.
10. Charney, D. S. and Heninger, G. R. (1986) Abnormal regulation of noradrenergic function in panic disorders: effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Archives of General Psychiatry 43, 1042-1054.
11. Cooney, N. L., Baker, L. H., Pomerleau, O. F. and Josephy, B. (1984) Salivation to drinking cues in alcohol abusers: toward the validation of a physiological measure of craving. Addictive Behaviors 9, 91-94.
12. Cornelius, J. R., Salloum, I. M., Cornelius, M. D., Perel, J. M., Thase, M. E., Ehler, J. G. and Mann, J. J. (1993) Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacology Bulletin 29, 195-199.
13. Cutter, H. S. G. and O'Farrell, T. J. (1987) Experience with alcohol and the endogenous opioid system in ethanol analgesia. Addictive Behaviors 12, 331-343.
14. Di Chiara, G. and Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences of the United States of America 85, 5274-5278.
15. Dorus, W., Ostrow, D. G., Anton, R., Cushman, P., Collins, J. F., Schaefer, M., Charles, H. L., Desai, P., Hayashida, M., Malkerneker, U., Willenbring, M., Fiscella, R. and Sather, M. R. (1989) Lithium treatment of depressed and nondepressed alcoholics. Journal of the American Medical Association 262, 1646-1652.
16. Erickson, C. K. (1996) Review of neurotransmitters and their role in alcoholism treatment. Alcohol and Alcoholism 31 (Suppl. 1), 5-11.
17. Fawcett, J., Clark, D. C., Aagesen, C. A., Pisani, V. D., Tilkin, J. M., Sellers, D., McGuire, M. and Gibbons, R. D. (1987) A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Archives of General Psychiatry 44, 248-256.
18. Froehlich, J. C. and Li, T.-K. (1991) Animal models for the study of alcoholism: utility of selected lines. Journal of Addictive Diseases 10, 61-71.
19. Goodman, W. K., Price, L. H., Delgado, P. L., Palumbo, J., Krystal, J. H., Nagy, L. M., Rasmussen, S. A., Heninger, G. R. and Charney, D. S. (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: comparison of fluvoxamine and desipramine. Archives of General Psychiatry 47, 577-585.
20. Gorelick, D. A. and Paredes, A. (1992) Effect of fluoxetine on alcohol consumption in male alcoholics. Alcoholism: Clinical and Experimental Research 16, 261-265.
21. Greb, J. (1995) A trial of ritanserin in patients with alcohol abuse. Presented at the New Clinical Drug Evaluation Unit annual meeting, Orlando, FL, May 31-June 3.
22. Hodgson, R., Rankin, H. and Stockwell, T. (1979) Alcohol dependence and the priming effect. Behaviour Research and Therapy 17, 379-387.
23. Jaffe, J. H., Kranzler, H. R. and Ciraulo, D. A. (1992) Drugs used in the treatment of alcoholism. In Medical Diagnosis and Treatment of Alcoholism, Mendelson, J. H. and Mello, N. K. eds, pp. 421-461. McGraw-Hill, New York.
24. Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., Wittchen, H.-U. and Kendler, K. S. (1994) Lifetime and 12-month preva-lence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8-19.
25. Koob, G. F. (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends in Pharmacological Sciences 13, 177-193.
26. Kranzler, H. R. and Anton, R. F. (1994) Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. Journal of Consulting and Clinical Psychology 62, 1116-1126.
27. Kranzler, H. R. and Orrok, B. (1989) The pharmacotherapy of alcoholism. Review of Psychiatry, 8, 359-379.
28. Kranzler, H. R., Burleson, J. A., Del Boca, F. K., Babor, T. F., Korner, P., Brown, J. and Bohn, M. J. (1994) Buspirone treatment of anxious alcoholics: a placebo-controlled trial. Archives of General Psychiatry 51, 720-731.
29. Kranzler, H. R., Burleson, J. A., Korner, P., Del Boca, F. K., Bohn, M. J., Brown, J. and Liebowitz, N. (1995) Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry 152, 391-397.
30. Krystal, J. H., Webb, E., Cooney, N., Kranzler, H. R. and Charney, D. S. (1994) Specificity of ethanol-like effects elicited by serotonergic and noradrenergic mechanisms. Archives of General Psychiatry 51, 898-911.
31. Lejoyeux, M. and Adès, J. (1993) Evaluation of lithium treatment in alcoholism. Alcohol and Alcoholism 28, 273-279.
32. Litten, R. Z. and Alien, J. P. (1991) Pharmacotherapies for alcoholism: promising agents and clinical issues. Alcoholism: Clinical and Experimental Research 15, 620-633.
33. Malcolm, R., Anton, R. F., Randall, C. L., Johnston, A., Brady, K. and Thevos, A. (1992) A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcoholism: Clinical and Experimental Research 16, 1007-1013.
34. Mason, B. J. and Kocsis, J. H. (1991) Desipramine treatment of alcoholism. Psychopharmacology Bulletin 27, 155-161.
35. Mason, B. J., Ritvo, E. C., Morgan, R. O., Salvato, F. R., Goldberg, G., Welch, B. and Mantero-Atienza, E. (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcoholism: Clinical and Experimental Research 18, 1162-1167.
36. McBride, W. J., Murphy, J. M., Lumeng, L. and Li, T.-K. (1990) Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats. Alcohol 7, 199-205.
37. Meyer, R. E. (1989) Prospects for a rational pharmacotherapy of alcoholism. Journal of Clinical Psychiatry 50, 403-412.
38. Modell, J. G., Glaser, F. B., Mountz, J. M., Schmaltz, S. and Cyr, L. (1992) Obsessive and compulsive characteristics of alcohol abuse and dependence: quantification by a newly developed questionnaire. Alcoholism: Clinical and Experimental Research 16, 266-271.
39. Monti, J. M. and Alterwain, P. (1991) Ritanserin decreases alcohol intake in chronic alcoholics. Lancet 337, 60.
40. Monti, P. M., Rohsenow, D. J., Rubonis, A. V., Niaura, R. S., Sirota, A. D., Colby, S. M. and Abrams, D. B. (1993) Alcohol cue reactivity: effects of detoxification and extended exposure. Journal of Studies on Alcohol 54, 235-245.
41. Morse, R. M. and Flavin, D. K. (1992) The definition of alcoholism. Journal of the American Medical Association 268, 1012-1014.
42. Naranjo, C. A. and Bremner, K. E. (1992) Evaluation of the effects of serotonin uptake inhibitors in alcoholics: a review. In Novel Pharmacological Interventions for Alcoholism, Naranjo, C. A. and Sellers, E. M. eds, pp. 105-117. Springer-Verlag, New York.
43. Naranjo, C. A. and Sellers, E. M. (1989) Serotonin uptake inhibitors attenuate ethanol intake in problem drinkers. In Recent Developments in Alcoholism: Treatment Research, Vol. 7, Galanter, M. ed., pp. 255-266. Plenum Press, New York.
44. Naranjo, C. A. and Sellers, E. M. eds (1992) Novel Pharmacological Interventions for Alcoholism. Springer-Verlag, New York.
45. Naranjo, C. A., Sellers, E. M., Roach, C. A., Woodley, D. V., Sanchez-Craig, M. and Sykora, K. (1984) Zimelidine-induced variations in alcohol intake by non-depressed heavy drinkers. Clinical Pharmacology and Therapeutics 35, 374-381.
46. Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley, D. V., Kadlec, K. and Sykora, K. (1987) The serotonin uptake inhibitor dtalopram attenuates ethanol intake. Clinical Pharmacology and Therapeutics 41, 266-274.
47. Naranjo, C. A., Kadlec, K. E., Sanhueza, P., Woodley-Remus, D. and Sellers, E. M. (1990) Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clinical Pharmacology and Therapeutics 47, 490-498.
48. Nunes, E. V., McGrath, P. J., Quitkin, F. M., Stewart, J. P., Harrison, W., Tricamo, E. and Ocepek-Welikson, K. (1993) Imipramine treatment of alcoholism with comorbid depression. American Journal of Psychiatry 150, 963-965.
49. O'Malley, S. S. (1996) Opioid antagonists in the treatment of alcohol dependence: clinical efficacy and prevention of relapse. Alcohol and Alcoholism 31 (Suppl. 1), 77-81.
50. O'Malley, S. S., Jaffe, A. J., Chang, G., Schottenfeld, R. S., Meyer, R. E. and Rounsaville, B. (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Archives of General Psychiatry 49, 881-887.
51. Pohorecky, L. A. (1991) Stress and alcohol interaction: an update of human research. Alcoholism: Clinical and Experimental Research 15, 438-459.
52. Project MATCH Research Group (1993) Project MATCH: Rationale and methods for a multisite clinical trial matching patients to alcoholism treatment. Alcoholism: Clinical and Experimental Research 17, 1130-1145.
53. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L. and Goodwin, F. K. (1990) Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) study. Journal of the American Medical Association 264, 2511-2518,
54. Richelson, E. (1991) Biological basis of depression and therapeutic relevance. Journal of Clinical Psychiatry 52 (Suppl. 6), 4-10.
55. Rinaldi, R. C., Steindler, E. M., Wilford, B. B. and Goodwin, D. (1988) Clarification and standardization of substance abuse terminology. Journal of the American Medical Association 259, 555-557.
56. Robinson, T. E. and Berridge, K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research Reviews 18, 247-291.
57. 3 antagonist ondansetron in alcohol abuse and alcohol dependence. Alcoholism: Clinical and Experimental Research 18, 879-885.
58. Swett, C., Jr, Cohen, C., Surrey, J., Compaine, A. and Chavez, R. (1991) High rates of alcohol use and history of physical and sexual abuse among women outpatients. American Journal of Drug and Alcohol Abuse 17, 49-60.
59. Task Force on DSM-IV (1994) Diagnostic and Statistical Manual for Mental Disorders: DSM-IV, 4th edn. American Psychiatric Association, Washington, DC.
60. 2-antagonist ritanserin. Neuroscience 22 (Suppl.), S42.
61. van der Kolk, B. A., Greenberg, M. S., Orr, S. P. and Pitman, R. K. (1989) Endogenous opioids, stress induced analgesia, and posttraumatic stress disorder. Psychopharmacology Bulletin 25, 417-421.
62. van Praag, H. M., Kahn, R. S., Asnis, G. M., Wetzler, S., Brown, S. L., Bleich, A. and Korn, M. L. (1987) Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders. Journal of Affective Disorders 13, 1-8.
63. van Ree, J. M. (1979) Reinforcing stimulus properties of drugs. Neuropharmacology 18, 963-969.
64. Volpicelli, J. R., Davis, M. A. and Olgin, J. E. (1986) Naltrexone blocks the post-shock increase of ethanol consumption. Life Sciences 38, 841-847.
65. Volpicelli, J. R., Ulm, R. R. and Hopson, N. (1990) The bidirectional effects of shock on alcohol preference in rats. Alcoholism: Clinical ana Experimental Research 14, 913-916.
66. Volpicelli, J. R., Alterman, A. I., Hayashida, M. and O'Brien, C. P. (1992) Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49, 876-880.
67. Weiss, F., Lorang, M. T., Bloom, F. E. and Koob, G. F. (1993) Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. Journal of Pharmacology and Experimental Therapeutics 267, 250-258.
68. Wise, R. A. and Rompre, P.-P. (1989) Brain dopamine and reward. Annual Review of Psychology 40, 191-225.
69. 3 receptors attenuates the effects of ethanol on extracellular dopamine. European Journal of Pharmacology 187, 287-289.